TNFRSF17 and B-cell chronic lymphocytic leukemia: Endo et al. demonstrated that BAFF supports CLL B cell survival through the activation of the canonical NF-κB pathway after binding to the B-cell maturation antigen (BCMA) or the transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI), two BAFF receptors (65).